Published in J Virol on August 01, 1985
Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol (1989) 4.08
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen. Mol Cell Biol (1986) 2.32
Specificity of retroviral RNA packaging. J Virol (1991) 2.22
A lysine in the ATP-binding site of P130gag-fps is essential for protein-tyrosine kinase activity. EMBO J (1986) 1.77
Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability. J Virol (1989) 1.53
DNA sequence encoding the amino-terminal region of the human c-src protein: implications of sequence divergence among src-type kinase oncogenes. Mol Cell Biol (1987) 1.41
Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins. J Virol (1986) 1.39
Structural differences between repressed and derepressed forms of p60c-src. Mol Cell Biol (1989) 1.23
Features of the pp60v-src carboxyl terminus that are required for transformation. Mol Cell Biol (1986) 1.17
Mutagenesis of avian carcinoma virus MH2: only one of two potential transforming genes (delta gag-myc) transforms fibroblasts. Proc Natl Acad Sci U S A (1985) 1.10
Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b. J Virol (1992) 1.09
The packaging phenotype of the SE21Q1b provirus is related to high proviral expression and not trans-acting factors. J Virol (1995) 0.97
Intracellular localization and processing of pp60v-src proteins expressed by two distinct temperature-sensitive mutants of Rous sarcoma virus. J Virol (1986) 0.97
A Swiss 3T3 variant cell line resistant to the effects of tumor promoters cannot be transformed by src. Mol Cell Biol (1990) 0.95
Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function. J Virol (1991) 0.95
Regulation of the oncogenic activity of the cellular src protein requires the correct spacing between the kinase domain and the C-terminal phosphorylated tyrosine (Tyr-527). Mol Cell Biol (1991) 0.91
v-src mutations outside the carboxyl-coding region are not sufficient to fully activate transformation by pp60c-src in NIH 3T3 cells. Mol Cell Biol (1988) 0.88
Avian proto-myc genes promoted by defective or nondefective retroviruses are single-hit transforming genes in primary cells. Proc Natl Acad Sci U S A (1989) 0.87
Inhibition of the tyrosine kinase activity of v-src, v-fgr, and v-yes gene products by a monoclonal antibody which binds both amino and carboxy peptide fragments of pp60v-src. J Virol (1987) 0.84
Expression of a molecularly cloned human c-src oncogene by using a replication-competent retroviral vector. Mol Cell Biol (1986) 0.82
A retroviral promoter is sufficient to convert proto-src to a transforming gene that is distinct from the src gene of Rous sarcoma virus. Proc Natl Acad Sci U S A (1990) 0.80
v-Src enhances phosphorylation at Ser-282 of the Rous sarcoma virus integrase. J Virol (1992) 0.80
Unmutated proto-src coding region is tumorigenic if expressed from the promoter of Rous sarcoma virus: implications for the gene-mutation hypothesis of cancer. Proc Natl Acad Sci U S A (1992) 0.79
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. J Immunol (1975) 47.77
Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene (1979) 25.53
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci U S A (1980) 22.30
Protein kinase activity associated with the avian sarcoma virus src gene product. Proc Natl Acad Sci U S A (1978) 18.32
Nucleotide sequence of Rous sarcoma virus. Cell (1983) 17.80
Identification of a transformation-specific antigen induced by an avian sarcoma virus. Nature (1977) 16.32
Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein. Cell (1978) 11.17
Cellular oncogenes and retroviruses. Annu Rev Biochem (1983) 10.65
Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell (1983) 7.37
Structural analysis of the avian sarcoma virus transforming protein: sites of phosphorylation. J Virol (1979) 7.13
Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine. Nature (1980) 6.69
A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation. Mol Cell Biol (1984) 6.40
Vinculin: a cytoskeletal target of the transforming protein of Rous sarcoma virus. Cell (1981) 5.74
Changes in protein phosphorylation in Rous sarcoma virus-transformed chicken embryo cells. Mol Cell Biol (1981) 5.67
The protein encoded by the transforming gene of avian sarcoma virus (pp60src) and a homologous protein in normal cells (pp60proto-src) are associated with the plasma membrane. Proc Natl Acad Sci U S A (1980) 4.99
Identification of a cellular protein substrate phosphorylated by the avian sarcoma virus-transforming gene product. Cell (1980) 4.79
Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). Proc Natl Acad Sci U S A (1981) 4.69
The transforming proteins of Rous sarcoma virus, Harvey sarcoma virus and Abelson virus contain tightly bound lipid. Cell (1982) 4.66
The specific interaction of the Rous sarcoma virus transforming protein, pp60src, with two cellular proteins. Cell (1981) 4.61
Avian sarcoma virus Y73 genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus. Nature (1982) 4.33
Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell (1982) 4.06
Amino terminal myristylation of the protein kinase p60src, a retroviral transforming protein. Science (1985) 3.97
Evidence that the Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. Proc Natl Acad Sci U S A (1984) 3.84
Evidence that the src gene product of Rous sarcoma virus is membrane associated. Virology (1980) 3.71
Transformation by Rous sarcoma virus: a cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine. Cell (1980) 3.70
Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts. Proc Natl Acad Sci U S A (1984) 3.70
Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog. J Virol (1985) 3.47
Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation. Cell (1983) 3.46
Evidence that the avian sarcoma virus transforming gene product is a cyclic AMP-independent protein kinase. Proc Natl Acad Sci U S A (1979) 3.35
Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin. J Virol (1984) 3.18
Expression of v-src and chicken c-src in rat cells demonstrates qualitative differences between pp60v-src and pp60c-src. Cell (1984) 3.06
Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein. Mol Cell Biol (1984) 2.98
Three glycolytic enzymes are phosphorylated at tyrosine in cells transformed by Rous sarcoma virus. Nature (1983) 2.47
Rous sarcoma virus transforming protein, p60src, expressed in E. coli, functions as a protein kinase. Nature (1981) 2.37
Antibodies to a defined region of pp60src neutralize the tyrosine-specific kinase activity. J Biol Chem (1983) 2.33
Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A (1984) 2.30
Transit of pp60v-src to the plasma membrane. Proc Natl Acad Sci U S A (1982) 2.29
Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis. Proc Natl Acad Sci U S A (1984) 2.23
Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation. J Virol (1982) 2.20
Amino acid alterations within a highly conserved region of the Rous sarcoma virus src gene product pp60src inactivate tyrosine protein kinase activity. Mol Cell Biol (1984) 2.18
Two cellular proteins that immunoprecipitate with the transforming protein of Rous sarcoma virus. Virology (1981) 2.16
Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src. Cell (1983) 1.98
Molecular cloning of avian sarcoma virus closed circular DNA: structural and biological characterization of three recombinant clones. J Virol (1980) 1.80
Isolation and partial characterization of a monoclonal antibody to the Rous sarcoma virus transforming protein pp60src. J Virol (1983) 1.31
HLA-A2 and HLA-B7 antigens are phosphorylated in vitro by rous sarcoma virus kinase (pp60v-src) at a tyrosine residue encoded in a highly conserved exon of the intracellular domain. Proc Natl Acad Sci U S A (1983) 1.20
Masking of extracellular collagen and the co-distribution of collagen and fibronectin during matrix formation by cultured embryonic fibroblasts. J Cell Sci (1982) 1.12
Immune response to the src gene product in mice bearing tumors induced by injection of avian sarcoma virus-transformed mouse cells. J Virol (1979) 1.11
Analysis of cellular integration sites in avian sarcoma virus infected duck embryo cells. J Virol (1979) 1.11
Site-directed point mutation in the src gene oF rous sarcoma virus results in an inactive src gene product. J Virol (1983) 1.10
pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A (1992) 8.46
Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol (1994) 7.53
Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci U S A (1990) 5.25
The nucleotide sequence complexity of avian tumor virus RNA. Proc Natl Acad Sci U S A (1974) 4.86
Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem (1992) 4.33
Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol (1995) 4.26
Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol (2001) 4.16
Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol (1994) 4.11
Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol (1989) 4.08
Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol (1992) 4.06
pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol Cell Biol (1995) 3.85
Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol (1991) 3.83
A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex (2001) 3.80
Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol (1993) 3.64
Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol (1993) 3.56
Biochemical studies on adenovirus multiplication. 18. Resolution of early virus-specific RNA species in Ad 2 infected and transformed cells. Virology (1971) 3.54
Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin. J Virol (1984) 3.18
Focal adhesion kinase and associated proteins. Curr Opin Cell Biol (1994) 3.06
Genetics of src: structure and functional organization of a protein tyrosine kinase. Curr Top Microbiol Immunol (1989) 3.03
Biochemical studies on adenovirus multiplication, XIX. Resolution of late viral RNA species in the nucleus and cytoplasm. Proc Natl Acad Sci U S A (1971) 3.02
Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol (2000) 2.94
Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene (2001) 2.77
p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J Biol Chem (1996) 2.77
Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol Cell Biol (1993) 2.75
Cell migration--movin' on. Science (1999) 2.72
Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem (1995) 2.68
Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67
Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell (1995) 2.57
Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse (2001) 2.56
Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins. Mol Cell Biol (1989) 2.49
Quantitative determination and location of newly synthesized virus-specific ribonucleic acid in chicken cells infected with Rous sarcoma virus. J Virol (1973) 2.45
An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol (1996) 2.38
Mechanism of carcinogenesis by RNA tumor viruses. 3. Formation of RNA, DNA complex and duplex DNA molecules by the DNA polymerase (s) of avian myeloblastosis virus. Proc Natl Acad Sci U S A (1970) 2.37
Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol Cell Biol (1997) 2.29
Site-directed mutagenesis of the src gene of Rous sarcoma virus: construction and characterization of a deletion mutant temperature sensitive for transformation. J Virol (1982) 2.20
Amino acid alterations within a highly conserved region of the Rous sarcoma virus src gene product pp60src inactivate tyrosine protein kinase activity. Mol Cell Biol (1984) 2.18
Avian retrovirus pp32 DNA-binding protein. I. Recognition of specific sequences on retrovirus DNA terminal repeats. J Virol (1982) 2.17
Tyrosine phosphorylation of a 120-kilodalton pp60src substrate upon epidermal growth factor and platelet-derived growth factor receptor stimulation and in polyomavirus middle-T-antigen-transformed cells. Mol Cell Biol (1991) 2.12
The SH2 and SH3 domains of pp60src direct stable association with tyrosine phosphorylated proteins p130 and p110. EMBO J (1991) 2.07
Incisional or excisional neck-node biopsy before definitive radiotherapy, alone or followed by neck dissection. Head Neck (1991) 2.07
Translocation of cortactin to the cell periphery is mediated by the small GTPase Rac1. J Cell Sci (1998) 1.99
Signal transduction through integrins: a central role for focal adhesion kinase? Bioessays (1995) 1.97
Adhesion-induced tyrosine phosphorylation of the p130 src substrate. J Cell Sci (1995) 1.95
In vitro synthesis of a unique RNA species by a T particle of vesicular stomatitis virus. J Virol (1977) 1.89
Intentional unsafe sex (barebacking) among HIV-positive gay men who seek sexual partners on the internet. AIDS Care (2003) 1.89
Immunoaffinity purification of tyrosine-phosphorylated cellular proteins. J Immunol Methods (1989) 1.87
Molecular cloning of avian sarcoma virus closed circular DNA: structural and biological characterization of three recombinant clones. J Virol (1980) 1.80
Studies on the structure and synthesis of Rous sarcoma virus RNA. Cold Spring Harb Symp Quant Biol (1975) 1.80
Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Oncogene Res (1988) 1.79
Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate. Mol Cell Biol (1993) 1.77
Focal adhesion kinase: an integrin-linked protein tyrosine kinase. Trends Cell Biol (1993) 1.70
Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol (1998) 1.68
Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. Mol Biol Cell (1999) 1.67
Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene (2001) 1.67
Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? Int J Radiat Oncol Biol Phys (1990) 1.66
RNase H hydrolysis of the 5' terminus of the avian sarcoma virus genome during reverse transcription. Nature (1978) 1.65
Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care (2003) 1.64
Construction of plasmids for expression of Rous sarcoma virus transforming protein, p60src, in Escherichia coli. Proc Natl Acad Sci U S A (1982) 1.63
Terminally repeated sequences in the avian sarcoma virus RNA genome. Proc Natl Acad Sci U S A (1977) 1.58
Integration of avian sarcoma virus DNA sequences in transformed mammalian cells. Proc Natl Acad Sci U S A (1977) 1.57
pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src. Mol Cell Biol (1989) 1.56
Local degradation of fibronectin at sites of expression of the transforming gene product pp60src. Nature (1985) 1.55
Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability. J Virol (1989) 1.53
In vitro synthesis of Rous sarcoma virus-specific RNA is catalyzed by a DNA-dependent RNA polymerase. Proc Natl Acad Sci U S A (1974) 1.53
Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem (1994) 1.53
Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys (1989) 1.51
Radiation therapy for skin cancer near the eye: kilovoltage x-rays versus electrons. Int J Radiat Oncol Biol Phys (1992) 1.51
Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase. J Cell Biol (1997) 1.50
Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol Cell Biol (2001) 1.49
SH2 domain specificity and activity modified by a single residue. Nature (1994) 1.44
The influence of dose and time on wound complications following post-radiation neck dissection. Int J Radiat Oncol Biol Phys (1992) 1.43
Regulated expression of focal adhesion kinase-related nonkinase, the autonomously expressed C-terminal domain of focal adhesion kinase. Mol Cell Biol (1999) 1.42
The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol Biol Cell (1996) 1.42
Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein. Mol Cell Biol (1991) 1.42
Is interstitial implantation essential for successful radiotherapeutic treatment of base of tongue carcinoma? Int J Radiat Oncol Biol Phys (1990) 1.41
Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein. Virology (1987) 1.41
Unnecessary irradiation of the normal larynx. Int J Radiat Oncol Biol Phys (1990) 1.40
A role for focal adhesion kinase in phenylephrine-induced hypertrophy of rat ventricular cardiomyocytes. J Biol Chem (2000) 1.40
Site-directed mutagenesis of the gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins. J Virol (1986) 1.39
The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci U S A (1993) 1.36
Tyrosine phosphorylation of the focal adhesion kinase pp125FAK during development: relation to paxillin. J Cell Sci (1993) 1.36
The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys (1983) 1.35
Awareness and use of untested barrier methods by HIV-seropositive gay and bisexual men. AIDS Educ Prev (2001) 1.35
A new approach to the isolation of RNA-DNA hybrids and its application to the quantitative determination of labeled tumor virus RNA. J Mol Biol (1974) 1.32
Isolation and partial characterization of a monoclonal antibody to the Rous sarcoma virus transforming protein pp60src. J Virol (1983) 1.31
Cytoskeletal changes induced by GRAF, the GTPase regulator associated with focal adhesion kinase, are mediated by Rho. J Cell Sci (1999) 1.29
The identification of p130cas-binding proteins and their role in cellular transformation. Oncogene (1996) 1.26
Expression and characterization of splice variants of PYK2, a focal adhesion kinase-related protein. J Cell Sci (1998) 1.25
Sexual behavior change among human immunodeficiency virus-infected adolescents with hemophilia. Adolescent Hemophilia Behavioral Intervention Evaluation Project Study Group. Pediatrics (2000) 1.21
Localization of conserved and nonconserved epitopes within the Rous sarcoma virus-encoded src protein. J Virol (1986) 1.19
Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck (1998) 1.17
Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck (1998) 1.17
Serine phosphorylation of focal adhesion kinase in interphase and mitosis: a possible role in modulating binding to p130(Cas). Mol Biol Cell (2001) 1.14
Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate. Oncogene (1992) 1.14
Immune response to the src gene product in mice bearing tumors induced by injection of avian sarcoma virus-transformed mouse cells. J Virol (1979) 1.11
Analysis of cellular integration sites in avian sarcoma virus infected duck embryo cells. J Virol (1979) 1.11
Identification of transcriptional elements within the long terminal repeat of Rous sarcoma virus. Mol Cell Biol (1983) 1.11
CT findings in chondroradionecrosis of the larynx. AJNR Am J Neuroradiol (1998) 1.11